Meeting
2018 Gastrointestinal Cancers Symposium
INNOVA: A phase II randomized study comparing INterval versus NeOadjuVAnt chemotherapy in magnetic resonance imaging-defined high risk rectal cancer.
Authors
Ramakrishnan Ayloor Seshadri
Cancer Institute (WIA), Chennai, India
Ramakrishnan Ayloor Seshadri , Trivadi S. Ganesan , Shirley Sundersingh , Arunkumar M N
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
CTRI/2015/01/005385
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr TPS879)
DOI
10.1200/JCO.2018.36.4_suppl.TPS879
Abstract #
TPS879
Poster Bd #
Q7
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
INNOVA: Interval or neoadjuvant chemotherapy in rectal cancer—A phase II randomized study comparing interval versus neoadjuvant chemotherapy in magnetic resonance imaging-defined high-risk rectal cancer.
First Author: Ramakrishnan Ayloor Seshadri
Poster
2017 ASCO Annual Meeting
Comparison of two different neoadjuvant chemoradiatiotherapy regimens for locally advanced rectal cancer: Results of a phase II, multicenter, randomized trial.
First Author: Ji Zhu
Poster
2015 ASCO Annual Meeting
Induction mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and surgery in high risk rectal cancer: Phase II randomized, multicenter, openlabel trial—The GEMCAD RIA study.
First Author: Carlos Fernandez-Martos
Poster
2014 Gastrointestinal Cancers Symposium
RAS mutations in expert-c, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (C) in MRI-defined, high-risk rectal cancer (RC).
First Author: Francesco Sclafani